drugset / Trial / NCT00619840

Placebo-Controlled Multi-Centre Double-Blind Trial for Adults With Extended-Release Methylphenidate for ADHD

NCT00619840

Phase 3 Completed 363 enrolled Medice Arzneimittel Pütter GmbH & Co KG
RandomizedParallel-groupQuadruple-blindTreatment

Summary

Investigation of efficacy and tolerability of extended-release MPD in adults with ADHD, compared with a placebo, and to acquire knowledge through long-term observation of adults

Timeline

Start
2004-11
Primary completion
2006-05
Completion

Drugs

EvaluationDrugModalityDoseRoute
Comparator Methylphenidate Small molecule 10 mg